Long-chain 3-hydroxy fatty acids accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies uncouple oxidative phosphorylation in heart mitochondria

J Bioenerg Biomembr. 2013 Feb;45(1-2):47-57. doi: 10.1007/s10863-012-9481-9. Epub 2012 Oct 13.

Abstract

Cardiomyopathy is a common clinical feature of some inherited disorders of mitochondrial fatty acid β-oxidation including mitochondrial trifunctional protein (MTP) and isolated long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiencies. Since individuals affected by these disorders present tissue accumulation of various fatty acids, including long-chain 3-hydroxy fatty acids, in the present study we investigated the effect of 3-hydroxydecanoic (3 HDCA), 3-hydroxydodecanoic (3 HDDA), 3-hydroxytetradecanoic (3 HTA) and 3-hydroxypalmitic (3 HPA) acids on mitochondrial oxidative metabolism, estimated by oximetry, NAD(P)H content, hydrogen peroxide production, membrane potential (ΔΨ) and swelling in rat heart mitochondrial preparations. We observed that 3 HTA and 3 HPA increased resting respiration and diminished the respiratory control and ADP/O ratios using glutamate/malate or succinate as substrates. Furthermore, 3 HDDA, 3 HTA and 3 HPA decreased ΔΨ, the matrix NAD(P)H pool and hydrogen peroxide production. These data indicate that these fatty acids behave as uncouplers of oxidative phosphorylation. We also verified that 3 HTA-induced uncoupling-effect was not mediated by the adenine nucleotide translocator and that this fatty acid induced the mitochondrial permeability transition pore opening in calcium-loaded organelles since cyclosporin A prevented the reduction of mitochondrial ΔΨ and swelling provoked by 3 HTA. The present data indicate that major 3-hydroxylated fatty acids accumulating in MTP and LCHAD deficiencies behave as strong uncouplers of oxidative phosphorylation potentially impairing heart energy homeostasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Hydroxyacyl CoA Dehydrogenases / deficiency
  • 3-Hydroxyacyl CoA Dehydrogenases / metabolism*
  • Animals
  • Cardiomyopathies / metabolism*
  • Fatty Acids / metabolism*
  • Hydrogen Peroxide / metabolism
  • Lipid Metabolism, Inborn Errors / metabolism*
  • Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase
  • Membrane Potential, Mitochondrial / physiology*
  • Mitochondria, Heart / metabolism*
  • Mitochondrial Myopathies
  • Mitochondrial Proteins / metabolism*
  • Mitochondrial Trifunctional Protein / deficiency
  • Muscle Proteins / metabolism*
  • Myocardium / metabolism*
  • Nervous System Diseases
  • Oxidation-Reduction
  • Oxidative Phosphorylation*
  • Oxygen Consumption
  • Peripheral Nervous System Diseases / metabolism*
  • Rats
  • Rats, Wistar
  • Retinitis Pigmentosa / metabolism*
  • Rhabdomyolysis

Substances

  • Fatty Acids
  • Mitochondrial Proteins
  • Muscle Proteins
  • Hydrogen Peroxide
  • 3-Hydroxyacyl CoA Dehydrogenases
  • Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase
  • Mitochondrial Trifunctional Protein

Supplementary concepts

  • Trifunctional Protein Deficiency With Myopathy And Neuropathy